Gefticip Tablet
Marketer
Cipla Ltd
Salt Composition
Gefitinib (250mg)
Overview Gefticip Tablet
Gefticip tablets treat advanced non-small cell lung cancer. This medication is prescribed for patients with metastatic disease, abnormal epidermal growth factor receptor (EGFR) genes, and no prior cancer therapy. Dosage should follow your physician's instructions, continuing treatment as directed. Treatment length depends on individual response. Your doctor might recommend regular liver function tests. Common adverse reactions include nausea, diarrhea, dry skin, and appetite loss. Increased fluid intake may lessen side effects. Report any bothersome or worsening side effects. Immediately contact your doctor if you experience mouth sores, vision changes, or respiratory problems. Women undergoing treatment should employ reliable contraception and avoid pregnancy throughout treatment and for one month afterward. Disclose all other medications you are currently using to your physician.
Uses of Gefticip Tablet
Lung cancer (non-small cell type)
Major Benefits of Gefticip Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Gefticip Tablet whole; avoid chewing, crushing, or breaking it. While Gefticip Tablets can be taken with or without food, consistent timing is recommended.
Common Side effects of Gefticip Tablet:
- Diarrhea
- Dry skin
- Loss of appetite
- Nausea
- Rash
- Vomiting
- Weakness
- Weight loss
- Eating disorder
- Allergic reaction
How to use Gefticip Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Gefticip Tablets can be taken with or without food, though consistent timing is recommended.
How Gefticip Tablet works:
Gefticip tablets are a cancer treatment that inhibits the activity of a faulty protein responsible for triggering uncontrolled cancer cell proliferation, thereby hindering or slowing cancerous growth.
SAFETY ADVICE
AlcoholUNSAFE
Avoid alcohol while taking Gefticip tablets.
PregnancyCONSULT YOUR DOCTOR
Using Gefticip Tablet during pregnancy is strongly discouraged due to confirmed risks to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingCONSULT YOUR DOCTOR
Breastfeeding while taking Gefticip tablets is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by Gefticip Tablet side effects.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Gefticip tablets, as dosage modification may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Using Gefticip Tablet in patients with liver disease appears safe, based on current limited evidence. Dose modification may not be necessary, but physician consultation is recommended.
What if you forget to take Gefticip Tablet :
Omit any missed Gefticip Tablet dose and resume your regular medication regimen. Avoid taking a double dose.
Facts to Know About Gefticip Tablet
| Label | Value |
|---|---|
| Chemical Type | Quinazoline amines |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
3,018 People bought this recently